Skip to main content
logo
Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.780
+0.110 (4.12%)
Aug 11, 2026, 4:00 PM EDT - Market closed

Serina Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.130.130.063.150.030.14
Revenue Growth
-132.14%-98.22%9173.53%-76.39%-60.11%
Gross Profit
0.130.130.063.150.020.13
Operating Income
-18.16-24.02-17.05-3.13-6.98-7.93
Net Income
-21.27-19.18-11.145.27-10.46-8.68
Earnings Per Share
-2.00-1.91-1.510.73-1.25-8.09
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
24.533.063.677.620.650.58
Total Debt
3.173.140.273.4518.1213.2
Net Cash (Debt)
21.36-0.093.44.17-17.48-12.62
Net Cash Growth
428.64%--18.45%---
Net Cash Per Share
1.98-0.010.460.57-8.15-11.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-18.2-17.96-17.14-2.48-5.94-15.62
Capital Expenditures
-0.08-0.06-0.02-0.5--
Free Cash Flow
-18.29-18.01-17.16-2.98-5.94-15.62
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%61.76%86.81%
Operating Margin
-13972.30%-18478.50%-30442.90%-99.24%-20514.70%-5509.03%
Pretax Margin
-16358.46%-14766.92%-20012.50%167.11%-30947.06%-5959.72%
Profit Margin
-16377.70%-14780.80%-20012.50%167.11%-30947.10%-6031.25%
FCF Margin
-14065.40%-13856.90%-30641.10%-94.51%-17467.60%-10847.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---18.84--
PS Ratio
320.72158.44842.9310.511256.22291.65